Glutamic Acid Decarboxylase Antibodies (GAD 65)
Private GAD 65 Antibodies testing in London for £208, measuring one autoimmune marker with specialist results expected in around 1 week.
Turnaround time
1 week
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Glutamic Acid Decarboxylase Antibodies (GAD 65) Test
The Glutamic Acid Decarboxylase Antibodies (GAD 65) blood test detects autoantibodies directed against the GAD65 enzyme.
The test assesses 1 specialist autoimmune marker: Glutamic Acid Decarboxylase Antibodies (GAD 65).
GAD65 is found within pancreatic beta cells as well as parts of the nervous system.
When the immune system produces antibodies against GAD65, this can provide evidence of autoimmune activity directed against insulin-producing beta cells.
GAD65 antibodies are therefore among the established autoantibodies used when investigating type 1 autoimmune diabetes.
They are also particularly relevant when an adult initially appears to have type 2 diabetes but the clinical pattern raises suspicion of latent autoimmune diabetes in adults, or LADA.
GAD65 is not the only pancreatic islet autoantibody.
Other markers, including Islet Cell Antibodies and additional diabetes-related antibodies, may be assessed depending on the clinical situation.
C-Peptide answers a different but complementary question by providing information about how much insulin the pancreas is still producing.
GAD65 antibodies can also occur in selected autoimmune neurological disorders.
However, neurological interpretation involves a different clinical context and specialist assessment, so a positive result should not be assumed to indicate neurological disease.
Equally, a negative GAD65 result does not exclude every form of autoimmune diabetes.
The result is most informative when interpreted alongside Glucose, HbA1c, C-Peptide, other islet autoantibodies and the person's clinical history.
What Does the Glutamic Acid Decarboxylase Antibodies (GAD 65) Test Check?
The test detects GAD65 autoantibodies and can provide evidence of pancreatic islet autoimmunity when autoimmune diabetes is being investigated. This test measures 1 specialist biomarker.
Glutamic Acid Decarboxylase Antibodies (GAD 65)
Detects autoantibodies against the GAD65 enzyme, an established marker of pancreatic islet autoimmunity used during investigation of type 1 diabetes and LADA.
Who May Benefit From the Glutamic Acid Decarboxylase Antibodies (GAD 65) Test?
GAD65 testing is particularly useful when there is uncertainty about whether diabetes has an autoimmune basis.
Adults with newly diagnosed diabetes and atypical features - Autoimmune diabetes can sometimes initially resemble type 2 diabetes.
People diagnosed with diabetes at a relatively young age - Autoantibody testing may help clarify the underlying mechanism where classification is uncertain.
People who require insulin sooner than expected after a type 2 diabetes diagnosis - This pattern can raise suspicion of LADA.
People with a personal history of autoimmune disease - Autoimmune conditions can cluster, although this does not mean diabetes is necessarily autoimmune.
People with a family history of type 1 diabetes or autoimmune disease - Family history can provide additional context when diabetes type is uncertain.
People undergoing a wider pancreatic autoantibody assessment - GAD65 may be measured alongside other islet-related antibodies.
People with an abnormal C-Peptide result and uncertain diabetes type - Autoantibody testing and endogenous insulin production answer complementary questions.
People specifically referred for specialist neurological autoantibody testing - GAD65 antibodies can be relevant in selected neurological autoimmune conditions under specialist care.
How to Prepare
Do not stop insulin or other prescribed diabetes treatment for this test.
GAD65 is an antibody measurement and should be interpreted alongside the clinical pattern rather than used as an isolated label for diabetes type.
Symptoms and Reasons to Consider the Glutamic Acid Decarboxylase Antibodies (GAD 65) Test
GAD65 antibodies themselves do not cause a unique symptom pattern. Testing is usually prompted by the clinical pattern of diabetes or a specialist autoimmune investigation.
Unexpectedly high blood glucose - Hyperglycaemia can prompt investigation of diabetes type once diabetes has been established.
Increased thirst and frequent urination - These are common symptoms of significant hyperglycaemia and require appropriate glucose assessment.
Unexplained weight loss with raised glucose - This pattern can occur when insulin production is insufficient.
Rapid progression from tablets to insulin treatment - Earlier-than-expected insulin requirement can raise suspicion of autoimmune diabetes in adults.
A diabetes diagnosis that does not fit a typical type 2 pattern - GAD65 testing can contribute to more accurate classification.
Other positive pancreatic autoantibodies - GAD65 can form part of a broader islet autoimmunity assessment.
A previous borderline or positive GAD65 result - Repeat or complementary testing may sometimes be appropriate.
Specialist investigation of possible neurological autoimmunity - GAD65 can also be measured in selected neurological settings.
The GAD65 antibody test does not measure current blood glucose and cannot diagnose diabetes by itself.
Anyone with severe hyperglycaemic symptoms, vomiting, abdominal pain, rapid breathing, marked dehydration, confusion or suspected diabetic ketoacidosis requires urgent medical assessment rather than waiting for an autoimmune antibody result.
How to Book Your Glutamic Acid Decarboxylase Antibodies (GAD 65) Test
The Glutamic Acid Decarboxylase Antibodies (GAD 65) test can be booked privately for specialist assessment of GAD65 autoimmunity.
Choose the Glutamic Acid Decarboxylase Antibodies (GAD 65)
Select the individual GAD65 antibody blood test online.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy where suitable.
Attend your appointment
A trained healthcare professional collects the required venous blood sample.
Laboratory analysis
Your serum undergoes specialist analysis for Glutamic Acid Decarboxylase Antibodies (GAD 65).
Receive your results securely
Your authorised result is delivered securely and can be interpreted alongside Glucose, C-Peptide and other diabetes-related investigations.
When Will I Receive My Results?
The current live London Blood Tests page lists a turnaround of approximately 1 week after laboratory receipt for Glutamic Acid Decarboxylase Antibodies (GAD 65).
This is a specialist autoantibody assay rather than a routine glucose measurement.
The laboratory performs dedicated immunological analysis, quality-control procedures and result authorisation.
Turnaround begins when the specimen reaches the laboratory rather than necessarily from the exact time of blood collection.
A complete investigation of uncertain diabetes type can take longer if C-Peptide or additional pancreatic autoantibodies are also required.
Understanding Your Results
A positive GAD65 antibody result indicates that autoantibodies against the GAD65 enzyme have been detected.
In a person with diabetes, this can provide evidence supporting autoimmune pancreatic beta-cell involvement.
It is particularly useful when distinguishing autoimmune diabetes from a typical type 2 diabetes pattern.
The assay cut-off and laboratory interpretation should be reviewed rather than applying an unrelated reference range.
A negative result makes detectable GAD65 autoimmunity less likely but does not exclude autoimmune diabetes completely.
Some people have other pancreatic autoantibodies without detectable GAD65 antibodies.
C-Peptide provides separate information about residual endogenous insulin production.
Glucose and HbA1c assess glycaemic status, while autoantibodies help investigate the underlying mechanism.
These measurements therefore answer different questions and can be more informative when interpreted together.
Why Book With London Blood Tests?
London Blood Tests provides private access to specialist GAD65 antibody measurement for autoimmune diabetes and selected specialist investigations.
Measures an established pancreatic autoantibody - GAD65 is one of the principal antibody markers used when autoimmune diabetes is being investigated.
Useful in possible LADA - Testing can help clarify diabetes classification in adults whose clinical pattern does not fit typical type 2 diabetes.
Can complement C-Peptide - Autoantibodies assess autoimmune activity while C-Peptide provides information about endogenous insulin production.
Can be combined with other islet antibody testing - Additional pancreatic autoantibodies can provide further information where required.
Specialist laboratory analysis - Samples undergo dedicated autoantibody measurement.
Clear specialist turnaround - Results are expected in approximately 1 week after laboratory receipt.
Professional blood collection - Clinic and suitable home or hotel phlebotomy appointments are available.
Clear pricing - The Glutamic Acid Decarboxylase Antibodies (GAD 65) test costs £208.
Private Glutamic Acid Decarboxylase Antibodies (GAD 65) Blood Test in London
London Blood Tests provides private GAD65 antibody testing for people requiring specialist investigation of pancreatic islet autoimmunity.
The test costs £208 and measures 1 specialist biomarker.
Results are expected approximately 1 week after laboratory receipt.
The result can support investigation of type 1 diabetes or LADA but should be interpreted alongside the clinical presentation, glucose control, C-Peptide and other pancreatic autoantibodies where appropriate.